Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | NEU1 | Q99519 | 9/20 | 0.36 |
| ▸ | NEU4 | Q8WWR8 | 6/20 | 0.36 |
| ▸ | NEU2 | Q9Y3R4 | 8/20 | 0.34 |
| ▸ | NEU3 | Q9UQ49 | 6/20 | 0.34 |
| ▸ | NANP | Q8TBE9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23640230 | 0.88 | L3MBTL1 (0.50) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL23591471 | 0.88 | L3MBTL1 (0.50) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL19960936 | 0.86 | L3MBTL1 (0.48) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL23640384 | 0.82 | NANP (0.53) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL25518923 | 0.82 | NANP (0.53) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL20122292 | 0.82 | NANP (0.53) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL15143174 | 0.81 | L3MBTL1 (0.72) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL15148465 | 0.81 | L3MBTL1 (0.72) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL22199276 | 0.81 | L3MBTL1 (0.51) | L3MBTL1NEU1NEU4NEU2NEU3 | |
| SCHEMBL10077898 | 0.81 | L3MBTL1 (0.72) | L3MBTL1NEU1NEU4NEU2NEU3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005807-B2 | Synthesis of sialylated/fucosylated human milk oligosaccharides | GLYCOM A/S (DK) | 2018-06-26 | — | — | US | disclosed |
| US-9963729-B2 | Diversification of human milk oligosaccharides (HMOs) or precursors thereof | GLYCOM A/S (DK) | 2018-05-08 | — | — | US | disclosed |
| US-20160289721-A1 | DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2016-10-06 | — | — | US | disclosed |
| US-9382564-B2 | Diversification of human milk oligosaccharides (HMOs) or precursors thereof | GLYCOM A/S (DK) | 2016-07-05 | — | — | US | disclosed |
| US-20160113952-A1 | Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal | GLYCOM A/S (DK) | 2016-04-28 | — | — | US | disclosed |
| US-20160075729-A1 | SYNTHESIS OF SIALYLATED/FUCOSYLATED HUMAN MILK OLIGOSACCHARIDES | GLYCOM A/S (DK) | 2016-03-17 | — | — | US | disclosed |
| US-20160024129-A1 | SYNTHESIS OF NEW SIALOOLIGOSACCHARIDE DERIVATIVES | GLYCOM A/S (DK) | 2016-01-28 | — | — | US | disclosed |
| US-9234225-B2 | Method for generating human milk oligosaccharides (HMOs) or precursors thereof | GLYCOM A/S (DK) | 2016-01-12 | — | — | US | disclosed |
| US-9102966-B2 | Synthesis of sialooligosaccharide derivatives | GLYCOM A/S (DK) | 2015-08-11 | — | — | US | disclosed |
| US-20150182549-A1 | METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK | GLYCOM A/S (DK) | 2015-07-02 | — | — | US | disclosed |
| US-20140248415-A1 | NUTRITIONAL PRODUCTS COMPRISING HUMAN MILK OLIGOSACCHARIDES AND METHODS FOR MANUFACTURE THEREOF | NESTEC S.A. (CH) | 2014-09-04 | — | — | US | disclosed |
| US-20140234912-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2014-08-21 | — | — | US | disclosed |
| US-20140212930-A1 | DIVERSIFICATION OF HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2014-07-31 | — | — | US | disclosed |
| US-20140057868-A1 | CATALYTIC HYDROGENOLYSIS OF A COMPOSITION OF A MIXTURE OF OLIGOSACCHARIDE PRECURSORS AND USES THEREOF | GLYCOM A/S (DK) | 2014-02-27 | — | — | US | disclosed |
| US-20130172548-A1 | DERIVATIZATION OF OLIGOSACCHARIDES | Glycom A/S, Kgs. (DK) | 2013-07-04 | — | — | US | disclosed |
| US-20130171696-A1 | SYNTHESIS OF NEW SIALOOLIGOSACCHARIDE DERIVATIVES | GLYCOM A/S (DK) | 2013-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172548-A1 | DERIVATIZATION OF OLIGOSACCHARIDES | OSTC, OGA, FUT5 | L3MBTL1 3544/4885NEU1 68/4885NEU4 20/4885 |
| US-20140057868-A1 | CATALYTIC HYDROGENOLYSIS OF A COMPOSITION OF A MIXTURE OF OLIGOSACCHARIDE PRECURSORS AND USES THEREOF | MGAM, SI, GALK1 | L3MBTL1 3111/4885NEU1 81/4885NEU4 125/4885 |
| US-20160075729-A1 | SYNTHESIS OF SIALYLATED/FUCOSYLATED HUMAN MILK OLIGOSACCHARIDES | FUT6, ST6GAL1, FUCA1 | L3MBTL1 708/4885NEU1 20/4885NEU4 39/4885 |
| US-10005807-B2 | Synthesis of sialylated/fucosylated human milk oligosaccharides | FUT6, ST6GAL1, ST3GAL3 | L3MBTL1 1328/4885NEU1 15/4885NEU4 28/4885 |
| US-20160113952-A1 | Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal | FUT5, FUT6, FUCA1 | L3MBTL1 646/4885NEU1 27/4885NEU4 34/4885 |
| US-20150182549-A1 | METHOD FOR ENZYMATIC GLYCOSYLATION OF OLIGOSACCHARIDES FROM MAMMALIAN ANIMAL MILK | GALE, SI, FUT6 | L3MBTL1 1631/4885NEU1 22/4885NEU4 20/4885 |
| US-20160024129-A1 | SYNTHESIS OF NEW SIALOOLIGOSACCHARIDE DERIVATIVES | FUCA1, FUT5, FUCA2 | L3MBTL1 2610/4885NEU1 9/4885NEU4 16/4885 |
| US-20140234912-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | LCT, B4GALT1, GALNT1 | L3MBTL1 460/4885NEU1 63/4885NEU4 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.